Leflunomide: an active antiinflammatory and antiproliferative agent in models of dermatologic disease.
Dermatology Division, Hoechst-Roussel Pharmaceuticals Inc., Somerville, NJ 08876-1258, USA.
E S
ES
Kurtz
S C
SC
Bailey
F
F
Arshad
A A
AA
Lee
P A
PA
Przekop
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001973:Bromodeoxyuridine; D002455:Cell Division / Q000187:drug effects; D002908:Chronic Disease; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D006801:Humans; D007555:Isoxazoles / Q000627:therapeutic use*; D000077339:Leflunomide; D007975:Leukotriene B4 / Q000378:metabolism; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009499:Neutral Red; D009195:Peroxidase / Q000037:antagonists & inhibitors; D010703:Phorbol Esters; D012871:Skin Diseases / Q000188:drug therapy* / Q000473:pathology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007555:Isoxazoles; D010703:Phorbol Esters; D007975:Leukotriene B4; D009499:Neutral Red; D009195:Peroxidase; D000077339:Leflunomide; D001973:Bromodeoxyuridine